Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
Main Authors: | Baras, Alexander S., Gandhi, Nilay, Munari, Enrico, Faraj, Sheila, Shultz, Luciana, Marchionni, Luigi, Schoenberg, Mark, Hahn, Noah, Hoque, Mohammad, Berman, David, Bivalacqua, Trinity J., Netto, George |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521868/ |
Similar Items
-
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
by: Baras, Alexander S., et al.
Published: (2015) -
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
by: Baras, Alexander S., et al.
Published: (2016) -
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine
by: Maldonado, Leonel, et al.
Published: (2014) -
Urothelial Carcinoma
by: Chow, Nan-Haw, et al.
Published: (2012) -
Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine
by: Hayashi, Masamichi, et al.
Published: (2014)